XML 25 R18.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-based Compensation
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation

9. Stock-based Compensation

As of March 31, 2025, there were 1,787,587 and 1,221,601 shares available for grant under The Hanover Insurance Group 2022 Long-Term Incentive Plan and 2023 Employee Stock Purchase plan, respectively.

Compensation cost for the Company’s stock-based awards and the related tax benefits were as follows:

 

 

Three Months Ended March 31,

 

(in millions)

 

2025

 

 

 

2024

 

Stock-based compensation expense

 

$

6.6

 

 

 

$

6.7

 

Tax benefit

 

 

(1.4

)

 

 

 

(1.4

)

Stock-based compensation expense, net of taxes

 

$

5.2

 

 

 

$

5.3

 

Stock Options

Information on the Company’s stock option activity for the three months ended March 31, 2025 and 2024 is summarized below.

 

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

(in whole shares and dollars)

 

Shares

 

 

Weighted Average
Exercise Price

 

 

Shares

 

 

Weighted Average
Exercise Price

 

Outstanding, beginning of period

 

 

1,111,871

 

 

$

117.43

 

 

 

1,137,042

 

 

$

111.57

 

Granted

 

 

140,393

 

 

 

161.82

 

 

 

150,731

 

 

 

134.26

 

Exercised

 

 

(92,520

)

 

 

89.99

 

 

 

(66,405

)

 

 

81.26

 

Forfeited or cancelled

 

 

 

 

 

 

 

 

(2,277

)

 

 

134.26

 

Outstanding, end of period

 

 

1,159,744

 

 

 

124.99

 

 

 

1,219,091

 

 

 

115.98

 

Restricted Stock Units

The Company currently issues time-based, market-based and performance-based restricted stock units to eligible employees, all of which generally vest after three years of continued employment.

The following table summarizes activity information about employee restricted stock units:

 

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

(in whole shares and dollars)

 

Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

 

Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Time-based restricted stock units:

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding, beginning of period

 

 

386,712

 

 

$

137.44

 

 

 

376,626

 

 

$

132.04

 

Granted

 

 

136,535

 

 

 

160.40

 

 

 

154,826

 

 

 

133.26

 

Vested

 

 

(118,406

)

 

 

139.49

 

 

 

(118,768

)

 

 

115.43

 

Forfeited

 

 

(2,108

)

 

 

140.39

 

 

 

(7,370

)

 

 

131.90

 

Outstanding, end of period

 

 

402,733

 

 

 

144.60

 

 

 

405,314

 

 

 

137.37

 

Performance-based and market-based restricted stock units:

 

 

 

 

 

 

 

 

 

 

 

Outstanding, beginning of period

 

 

126,211

 

 

$

140.47

 

 

 

120,504

 

 

$

132.76

 

Granted

 

 

52,360

 

 

 

178.39

 

 

 

53,336

 

 

 

132.27

 

Vested

 

 

(31,052

)

 

 

141.58

 

 

 

(41,290

)

 

 

112.36

 

Forfeited

 

 

(14,369

)

 

 

152.88

 

 

 

(6,339

)

 

 

108.06

 

Outstanding, end of period

 

 

133,150

 

 

 

153.78

 

 

 

126,211

 

 

 

140.47

 

 

In the first three months of 2025 and 2024, the Company granted market-based awards totaling 23,492 shares and 25,414 shares, respectively, to certain members of senior management, which are included in the table above as performance and market-based restricted stock activity. The vesting of these stock units is based on the relative total shareholder return (“TSR”) of the Company. This metric is generally based on relative TSR for a three-year period as compared to a pre-selected group of property and casualty companies. The fair value of market-based awards was estimated at the date of grant using a valuation model. These units have the potential to range from 0% to 200% of the shares disclosed for grant year 2025 and from 0% to 150% of the shares disclosed for grant years 2024 and 2023. The amounts reported as forfeited in the table above in 2025 and 2024 of 14,369 shares and 6,339 shares, respectively, related to market-based awards that achieved a payout below 100%. These awards were forfeited in the first quarter of 2025 and 2024, respectively.

The Company also granted performance-based restricted stock units in 2025 and 2024, totaling 28,868 shares and 27,992 shares, respectively, which are based upon the Company’s achievement of return on equity objectives. These units have the potential to range from 0% to 200% of the shares disclosed for grant year 2025 and from 0% to 150% of the shares disclosed for grant years 2024 and 2023. Increases above the 100% target level are reflected as granted in the period after which performance-based stock unit goals are achieved. Decreases below the 100% target level are reflected as forfeited. Included in the amounts granted above in 2025 and 2024 are 5,246 shares and 2,615 shares, respectively, related to performance-based awards that achieved a payout in excess of 100%. These awards vested in the first quarter of 2025 and 2024, respectively.